DGAT2 and fatty liver disease: In line with this assumption, hepatic overexpression of DGAT2 markedly increased DAG levels in the liver of the transgenic mice [24] and knockdown of MGAT1 expression protected mice from HFD and PPARg-induced hepatic steatosis, respectively [40].